From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Survival of myeloma patients has greatly improved with the use of autologous stem cell transplantation and novel agents, such as proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies. Compared to bortezomib- and lenalidomide-based regimens alone, the addition of high-dose melphalan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Haematologica
Autori principali: Gay, Francesca, Engelhardt, Monika, Terpos, Evangelos, Wäsch, Ralph, Giaccone, Luisa, Auner, Holger W., Caers, Jo, Gramatzki, Martin, van de Donk, Niels, Oliva, Stefania, Zamagni, Elena, Garderet, Laurent, Straka, Christian, Hajek, Roman, Ludwig, Heinz, Einsele, Herman, Dimopoulos, Meletios, Boccadoro, Mario, Kröger, Nicolaus, Cavo, Michele, Goldschmidt, Hartmut, Bruno, Benedetto, Sonneveld, Pieter
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2018
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792264/
https://ncbi.nlm.nih.gov/pubmed/29217780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.174573
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi